art_29__para_2__point_a__point_iv__text_1 — Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16… · Lexiara

art_29__para_2__point_a__point_iv__text_1

Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance · European Union

the possible treatment alternatives, including the follow-up measures if the participation of the subject in the clinical trial is discontinued;

← (iv) · All articles · (b) →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.